These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35445748)

  • 1. Pharmacokinetics of intravenous, oral transmucosal, and intranasal buprenorphine in healthy male dogs.
    Enomoto H; Love L; Madsen M; Wallace A; Messenger KM
    J Vet Pharmacol Ther; 2022 Jul; 45(4):358-365. PubMed ID: 35445748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of buprenorphine following intravenous and oral transmucosal administration in dogs.
    Abbo LA; Ko JC; Maxwell LK; Galinsky RE; Moody DE; Johnson BM; Fang WB
    Vet Ther; 2008; 9(2):83-93. PubMed ID: 18597246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of buprenorphine after intravenous and oral transmucosal administration in guinea pigs (Cavia porcellus).
    Sadar MJ; Knych HK; Drazenovich TL; Paul-Murphy JR
    Am J Vet Res; 2018 Mar; 79(3):260-266. PubMed ID: 29466036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of detomidine following intravenous or oral-transmucosal administration and sedative effects of the oral-transmucosal treatment in dogs.
    Messenger KM; Hopfensperger M; Knych HK; Papich MG
    Am J Vet Res; 2016 Apr; 77(4):413-20. PubMed ID: 27027842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and pharmacodynamic effects of oral transmucosal and intravenous administration of dexmedetomidine in dogs.
    Dent BT; Aarnes TK; Wavreille VA; Lakritz J; Lerche P; KuKanich B; Riccó Pereira CH; Bednarski RM
    Am J Vet Res; 2019 Oct; 80(10):969-975. PubMed ID: 31556717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic and pharmacodynamic modelling after subcutaneous, intravenous and buccal administration of a high-concentration formulation of buprenorphine in conscious cats.
    Doodnaught GM; Monteiro BP; Benito J; Edge D; Beaudry F; Pelligand L; Steagall P
    PLoS One; 2017; 12(4):e0176443. PubMed ID: 28445495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and analgesic effects of intravenous, intramuscular or subcutaneous buprenorphine in dogs undergoing ovariohysterectomy: a randomized, prospective, masked, clinical trial.
    Steagall PV; Ruel HLM; Yasuda T; Monteiro BP; Watanabe R; Evangelista MC; Beaudry F
    BMC Vet Res; 2020 May; 16(1):154. PubMed ID: 32448336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic Characterisation and Comparison of Bioavailability of Intranasal Fentanyl, Transmucosal, and Intravenous Administration through a Three-Way Crossover Study in 24 Healthy Volunteers.
    Nardi-Hiebl S; Ndieyira JW; Al Enzi Y; Al Akkad W; Koch T; Geldner G; Reyher C; Eberhart LHJ
    Pain Res Manag; 2021; 2021():2887773. PubMed ID: 34880961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of oral transmucosal and intramuscular dexmedetomidine combined with buprenorphine in cats.
    Porters N; de Rooster H; Bosmans T; Baert K; Cherlet M; Croubels S; De Backer P; Polis I
    J Vet Pharmacol Ther; 2015 Apr; 38(2):203-8. PubMed ID: 25269566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of oral transmucosal and intravenous administration of buprenorphine before surgery for postoperative analgesia in dogs undergoing ovariohysterectomy.
    Ko JC; Freeman LJ; Barletta M; Weil AB; Payton ME; Johnson BM; Inoue T
    J Am Vet Med Assoc; 2011 Feb; 238(3):318-28. PubMed ID: 21281215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of a high-concentration formulation of buprenorphine (Simbadol) in male dogs.
    Hansford J; Henao-Guerrero N; Machado ML; Pypendop BH
    Vet Anaesth Analg; 2021 Jul; 48(4):509-516. PubMed ID: 34059460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics, absolute bioavailability and tolerability of ketamine after intranasal administration to dexmedetomidine sedated dogs.
    Vlerick L; Devreese M; Peremans K; Dockx R; Croubels S; Duchateau L; Polis I
    PLoS One; 2020; 15(1):e0227762. PubMed ID: 31929589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PK-PD modeling of buprenorphine in cats: intravenous and oral transmucosal administration.
    Robertson SA; Lascelles BD; Taylor PM; Sear JW
    J Vet Pharmacol Ther; 2005 Oct; 28(5):453-60. PubMed ID: 16207308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioavailability of subcutaneous and intramuscular administrated buprenorphine in New Zealand White rabbits.
    Askar R; Fredriksson E; Manell E; Hedeland M; Bondesson U; Bate S; Olsén L; Hedenqvist P
    BMC Vet Res; 2020 Nov; 16(1):436. PubMed ID: 33176781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sedative and antinociceptive effects of dexmedetomidine and buprenorphine after oral transmucosal or intramuscular administration in cats.
    Porters N; Bosmans T; Debille M; de Rooster H; Duchateau L; Polis I
    Vet Anaesth Analg; 2014 Jan; 41(1):90-6. PubMed ID: 23910721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of buprenorphine in a sodium carboxymethylcellulose gel after buccal transmucosal administration in dogs.
    Krotscheck U; Boothe DM; Little AA; Erb HN
    Vet Ther; 2010; 11(3):E1-8. PubMed ID: 20960411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human pharmacokinetics of intravenous, sublingual, and buccal buprenorphine.
    Kuhlman JJ; Lalani S; Magluilo J; Levine B; Darwin WD
    J Anal Toxicol; 1996 Oct; 20(6):369-78. PubMed ID: 8889672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative analgesic effects of intravenous, intramuscular, subcutaneous or oral transmucosal buprenorphine administered to cats undergoing ovariohysterectomy.
    Giordano T; Steagall PV; Ferreira TH; Minto BW; de Sá Lorena SE; Brondani J; Luna SP
    Vet Anaesth Analg; 2010 Jul; 37(4):357-66. PubMed ID: 20636568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of buprenorphine hydrochloride following intramuscular and intravenous administration to American kestrels (Falco sparverius).
    Gustavsen KA; Guzman DS; Knych HK; Petritz OA; Olsen GH; Paul-Murphy JR
    Am J Vet Res; 2014 Aug; 75(8):711-5. PubMed ID: 25061701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sedative and cardiorespiratory effects of dexmedetomidine and buprenorphine administered to cats via oral transmucosal or intramuscular routes.
    Santos LC; Ludders JW; Erb HN; Basher KL; Kirch P; Gleed RD
    Vet Anaesth Analg; 2010 Sep; 37(5):417-24. PubMed ID: 20712608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.